In 2018, the Regenerative Pain Therapies Program (RPTP) was launched at Duke Innovative Pain Therapies, under the direction of Dr. Thomas Buchheit. Duke’s RPTP was built around well-proven and tested clinical interventions with demonstrated records of successful outcomes. This program offers a full spectrum of biologically- and non-biologically-based interventions to treat specific types of musculoskeletal injuries and degenerative conditions of joints, tendons and muscle. Dr. Buchheit has more than 10 years of experience with ultrasound-guided musculoskeletal (MSK) diagnosis and ultrasound-guided interventions, which he employs for precision therapies. In addition to formal certification in ultrasound-guided MSK intervention, Dr. Buchheit has mentored with Dr. Peter Wehling, an internationally-renowned expert in molecular orthopedics and regenerative medicine from Düsseldorf, Germany. Dr. Wehling, adjunct professor in Duke Anesthesiology, has been instrumental in the development of Duke’s Regenerative Pain Therapies Program, including Duke Autologous Serum, a treatment honed after decades of research and clinical practice by Dr. Peter Wehling for the treatment of patients with degenerative joint disease. Therapy is customized for each patient, and may also include acupuncture, massage and physical therapy. This process has successfully treated thousands of patients across the globe, avoiding the need for surgical intervention.